Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases
Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused…
Browsing Tag
GV
7 posts
Waltz Health Launches Waltz Connect to Revolutionize Specialty Medication Coverage
Key Highlights Waltz Health unveils Waltz Connect, a transformative end-to-end solution for specialty medication coverage. Leverages AI-powered technology for…
EveryONE Medicines Appoints New CEO and Chairman
Key Highlights Kent Rogers appointed as CEO and Josh Ofman, MD, MSHS as Chairman. First biotech company dedicated to personalized genetic medicines.…
Santa Ana Bio Emerges with $168M Funding to Advance Precision Immunology
Key Highlights Santa Ana Bio secures $168M in Series A and B funding rounds. Versant Ventures, GV, and…
Oula Secures $28M to Transform Maternity Care
Key Highlights Oula announces $28M Series B funding to expand beyond NYC and launch new reproductive services. Plans to…
Seismic Therapeutic Secures $121 Million in Series B Funding for Advanced Immunology Drug Development
Key Highlights Seismic Therapeutic, Inc., a machine learning immunology company, announces a $121 million Series B financing, led by Bessemer Venture…
Midi Health Secures $25M in Series A Funding to Transform Women’s Midlife Healthcare
Key Highlights Midi Health closes a $25M Series A funding round led by GV (Google Ventures). Total funding…